This was in agreement with a Kazakhstani study that reported on reduced MIF serum levels in metastatic CRC [46], and a Taiwanese study that documented that BLC deficiency and blockade of signaling attenuate CRC progression and metastasis [33]. Here, CXCL13 is linked to colorectal carcinoma.